Caxton Associates (New York)’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,799
Closed -$196K 635
2021
Q2
$196K Hold
11,799
0.02% 422
2021
Q1
$214K Buy
+11,799
New +$233K 0.02% 362

Other funds holding NXGN

Caxton Associates (New York)'s NXGN Position: Q3 2021 in Review

Caxton Associates (New York) sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2021, closing a stake of 11,799 shares — an estimated $196K sold.

Caxton Associates (New York) first reported a position in NXGN in Q1 2021 and held it in 2 quarters. The position peaked at $214K in Q1 2021. 157 funds tracked by Wall St. Rank hold NXGN as of Q3 2021.

  • Caxton Associates (New York) reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,799 NextGen Healthcare, Inc. Common Stock shares in Q3 2021, an estimated $196K.
  • Caxton Associates (New York) first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s NextGen Healthcare, Inc. Common Stock position peaked at $214K in Q1 2021.
  • 157 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.